Axovant Sciences Ltd. operates as a clinical-stage biopharmaceutical company. The Company focuses on the acquisition, development, and commercialization of novel therapeutics for the treatment of neurological disorders. Axovant Sciences develops products to treat the cognitive impairment and behavioral disturbances associated with dementia.
2 Church Street
Hamilton, HM 11